The Chinese government has allocated CNY 6.6 billion ($880 billion) to drug discovery and development. The program will select Chinese companies, universities and research institutes to develop drugs for 10 disease areas (malignant tumors, heart disease, cardiovascular systems ailments, nervous system diseases, diabetes, psychosis, autoimmune problems, drug resistant infections, viral infectious diseases and tuberculosis). The […]
The IBO Life Science Index sales grew 8.3% in the third quarter to $2,255 million, compared to 11.2% growth in the same period last year due to declining sales from companies, such as Affymetrix and Caliper Life Sciences and reduced currency effects. Operating profit for the Index climbed 19.3% to $375 million and operating margin […]
The discovery of the toxic combination of melamine and cyanuric acid in food supplies worldwide continues to spread. From the announcement in September of melamine in Chinese baby formula, to the most recent reports of its presence in a wide range of food products containing milk or milk-derived ingredients, the melamine scare grows daily (see […]
Even a new president-elect could not appease the markets. Increased anxiety over the credit markets and potential bankruptcies by the auto industry and remaining national banks propelled markets on an unrelenting decline. In the two days beginning November 4, the Dow Jones Industrial Average, S&P 500 and NASDAQ fell 9.7%, 10.0% and 9.6%, respectively. However, […]
The International Cancer Genome Consortium (ICGC) has announced projects in eight countries involving 11 funding organizations to study the genomic changes in eight forms of cancer. Each projects is expected to cost $20 million. Source: ICGC
Company Announcements GENEART AG extended its strategic collaboration with QIAGEN NV to include synthetic human genes optimized for use in insect or mammalian cells in addition to those designed for production in E.coli bacteria. GENEART AG established a subsidiary on the US West Coast in San Francisco, California. Invitrogen named Joe Beery as head of […]
Company Announcements Ahura Scientific announced three new distributors: Nucletron Technologies GmbH for Germany and Austria, HazmatLINK for the UK and Benelux, and RMI for the Czech and Slovak Republics. T-Ray Science exclusively licensed MIT’s technology for dual-mode, pulsed and continuous TeraHertz waves. Product Introductions X-Rite launched the xDNA system with the M98 handheld spectrophotometer for […]
Goettingen, Germany 10/31/08—Sartorius Stedim Biotech GmbH has acquired Wave Biotech AG, a developer of single-use bioreactors for bipharmaceutical manufacturing, for an undisclosed amount. The two companies have worked together since 2006 and Sartorius Stedim Biotech exclusively markets Wave Biotech’s products, Wave Biotech’s products are expected to contribute €10 million ($13 million) in revenues this year […]
Following years of governmental disinterest, Argentinian researchers are greeting last year’s election of President Cristina Fernández de Kirchner as a turning point. In addition to establishing the Ministry of Science, Technology and Productive Innovation, she plans to increase science and technology investments from 0.66% of GDP to 1% of GDP by 2010. To reverse the […]
The Chinese Academy of Science (CAS) has released a draft of its plan to promote the sharing of research instruments and development of new instrumentation by researchers. The plan is designed to improve coordination among CAS scientists by centralizing research facilities. Under the plan, between 30 and 50 pilot centers will be established. CAS would […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
